nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—HTR2B—Sorafenib—thyroid cancer	0.13	0.231	CbGbCtD
Chlorpromazine—ABCB11—Doxorubicin—thyroid cancer	0.0956	0.169	CbGbCtD
Chlorpromazine—ALB—Vandetanib—thyroid cancer	0.0857	0.152	CbGbCtD
Chlorpromazine—HTR2C—Sorafenib—thyroid cancer	0.0849	0.15	CbGbCtD
Chlorpromazine—CYP1A2—Sorafenib—thyroid cancer	0.0309	0.0547	CbGbCtD
Chlorpromazine—ABCB1—Sorafenib—thyroid cancer	0.027	0.0478	CbGbCtD
Chlorpromazine—CYP3A4—Vandetanib—thyroid cancer	0.0269	0.0476	CbGbCtD
Chlorpromazine—CYP2D6—Sorafenib—thyroid cancer	0.0255	0.0451	CbGbCtD
Chlorpromazine—Keratopathy—Vandetanib—thyroid cancer	0.0251	0.166	CcSEcCtD
Chlorpromazine—ABCB1—Doxorubicin—thyroid cancer	0.0164	0.029	CbGbCtD
Chlorpromazine—CYP3A4—Sorafenib—thyroid cancer	0.0162	0.0287	CbGbCtD
Chlorpromazine—CYP2D6—Doxorubicin—thyroid cancer	0.0154	0.0273	CbGbCtD
Chlorpromazine—Brain oedema—Vandetanib—thyroid cancer	0.0119	0.0787	CcSEcCtD
Chlorpromazine—CYP3A4—Doxorubicin—thyroid cancer	0.00982	0.0174	CbGbCtD
Chlorpromazine—Sudden death—Vandetanib—thyroid cancer	0.00663	0.044	CcSEcCtD
Chlorpromazine—Endocrine disorder—Vandetanib—thyroid cancer	0.0041	0.0271	CcSEcCtD
Chlorpromazine—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.00315	0.0209	CcSEcCtD
Chlorpromazine—Endocrine disorder—Sorafenib—thyroid cancer	0.00276	0.0183	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Epirubicin—thyroid cancer	0.00254	0.0168	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Vandetanib—thyroid cancer	0.00253	0.0167	CcSEcCtD
Chlorpromazine—SMPD1—thyroid gland—thyroid cancer	0.00236	0.0374	CbGeAlD
Chlorpromazine—Pigmentation disorder—Doxorubicin—thyroid cancer	0.00235	0.0156	CcSEcCtD
Chlorpromazine—Cardiac arrest—Vandetanib—thyroid cancer	0.00234	0.0155	CcSEcCtD
Chlorpromazine—Dysphagia—Vandetanib—thyroid cancer	0.00213	0.0141	CcSEcCtD
Chlorpromazine—Influenza—Vandetanib—thyroid cancer	0.00213	0.0141	CcSEcCtD
Chlorpromazine—SMPD1—head—thyroid cancer	0.00209	0.0332	CbGeAlD
Chlorpromazine—Gynaecomastia—Sorafenib—thyroid cancer	0.00205	0.0136	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00194	0.0129	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Vandetanib—thyroid cancer	0.00192	0.0127	CcSEcCtD
Chlorpromazine—CALM2—neck—thyroid cancer	0.0018	0.0286	CbGeAlD
Chlorpromazine—CALM1—neck—thyroid cancer	0.00179	0.0285	CbGeAlD
Chlorpromazine—CALM3—saliva-secreting gland—thyroid cancer	0.00179	0.0284	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00176	0.0117	CcSEcCtD
Chlorpromazine—HTR7—neck—thyroid cancer	0.00175	0.0278	CbGeAlD
Chlorpromazine—DRD3—head—thyroid cancer	0.00165	0.0262	CbGeAlD
Chlorpromazine—Visual impairment—Vandetanib—thyroid cancer	0.00164	0.0109	CcSEcCtD
Chlorpromazine—CHRM1—saliva-secreting gland—thyroid cancer	0.00161	0.0255	CbGeAlD
Chlorpromazine—HTR6—head—thyroid cancer	0.00159	0.0253	CbGeAlD
Chlorpromazine—DRD5—head—thyroid cancer	0.00155	0.0246	CbGeAlD
Chlorpromazine—SMPD1—lymph node—thyroid cancer	0.00146	0.0232	CbGeAlD
Chlorpromazine—Dysphagia—Sorafenib—thyroid cancer	0.00144	0.00952	CcSEcCtD
Chlorpromazine—CHRM3—saliva-secreting gland—thyroid cancer	0.00144	0.0228	CbGeAlD
Chlorpromazine—Muscle spasms—Vandetanib—thyroid cancer	0.00143	0.00946	CcSEcCtD
Chlorpromazine—CALM2—saliva-secreting gland—thyroid cancer	0.00141	0.0223	CbGeAlD
Chlorpromazine—CALM1—saliva-secreting gland—thyroid cancer	0.0014	0.0222	CbGeAlD
Chlorpromazine—Tremor—Vandetanib—thyroid cancer	0.00139	0.00922	CcSEcCtD
Chlorpromazine—CALM3—trachea—thyroid cancer	0.00138	0.0219	CbGeAlD
Chlorpromazine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00132	0.00877	CcSEcCtD
Chlorpromazine—Loss of consciousness—Vandetanib—thyroid cancer	0.0013	0.00865	CcSEcCtD
Chlorpromazine—Cough—Vandetanib—thyroid cancer	0.0013	0.00858	CcSEcCtD
Chlorpromazine—Convulsion—Vandetanib—thyroid cancer	0.00129	0.00852	CcSEcCtD
Chlorpromazine—ADRA1B—head—thyroid cancer	0.00127	0.0202	CbGeAlD
Chlorpromazine—Jaundice—Sorafenib—thyroid cancer	0.00125	0.00828	CcSEcCtD
Chlorpromazine—CHRM1—trachea—thyroid cancer	0.00124	0.0196	CbGeAlD
Chlorpromazine—Dry mouth—Vandetanib—thyroid cancer	0.00124	0.00819	CcSEcCtD
Chlorpromazine—Infection—Vandetanib—thyroid cancer	0.0012	0.00798	CcSEcCtD
Chlorpromazine—DRD1—head—thyroid cancer	0.00118	0.0188	CbGeAlD
Chlorpromazine—Insomnia—Vandetanib—thyroid cancer	0.0011	0.00726	CcSEcCtD
Chlorpromazine—HTR2A—neck—thyroid cancer	0.00109	0.0173	CbGeAlD
Chlorpromazine—CALM3—thyroid gland—thyroid cancer	0.00109	0.0173	CbGeAlD
Chlorpromazine—CALM2—trachea—thyroid cancer	0.00108	0.0172	CbGeAlD
Chlorpromazine—Dyspnoea—Vandetanib—thyroid cancer	0.00108	0.00716	CcSEcCtD
Chlorpromazine—CALM1—trachea—thyroid cancer	0.00108	0.0171	CbGeAlD
Chlorpromazine—HTR7—trachea—thyroid cancer	0.00105	0.0167	CbGeAlD
Chlorpromazine—Glycosuria—Epirubicin—thyroid cancer	0.00104	0.00693	CcSEcCtD
Chlorpromazine—Constipation—Vandetanib—thyroid cancer	0.00104	0.00687	CcSEcCtD
Chlorpromazine—Blood disorder—Epirubicin—thyroid cancer	0.00101	0.00672	CcSEcCtD
Chlorpromazine—HTR2B—thyroid gland—thyroid cancer	0.000974	0.0155	CbGeAlD
Chlorpromazine—Glycosuria—Doxorubicin—thyroid cancer	0.000967	0.00641	CcSEcCtD
Chlorpromazine—Amenorrhoea—Epirubicin—thyroid cancer	0.000963	0.00639	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Epirubicin—thyroid cancer	0.000963	0.00639	CcSEcCtD
Chlorpromazine—Muscle spasms—Sorafenib—thyroid cancer	0.000962	0.00638	CcSEcCtD
Chlorpromazine—Body temperature increased—Vandetanib—thyroid cancer	0.000957	0.00635	CcSEcCtD
Chlorpromazine—CHRM2—head—thyroid cancer	0.000955	0.0151	CbGeAlD
Chlorpromazine—SLC22A1—head—thyroid cancer	0.000938	0.0149	CbGeAlD
Chlorpromazine—Blood disorder—Doxorubicin—thyroid cancer	0.000938	0.00622	CcSEcCtD
Chlorpromazine—HTR2C—head—thyroid cancer	0.00092	0.0146	CbGeAlD
Chlorpromazine—Angioedema—Sorafenib—thyroid cancer	0.000915	0.00606	CcSEcCtD
Chlorpromazine—BCHE—trachea—thyroid cancer	0.000904	0.0143	CbGeAlD
Chlorpromazine—Dyskinesia—Epirubicin—thyroid cancer	0.000901	0.00597	CcSEcCtD
Chlorpromazine—Syncope—Sorafenib—thyroid cancer	0.000898	0.00595	CcSEcCtD
Chlorpromazine—Leukopenia—Sorafenib—thyroid cancer	0.000896	0.00594	CcSEcCtD
Chlorpromazine—Amenorrhoea—Doxorubicin—thyroid cancer	0.000891	0.00591	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.000891	0.00591	CcSEcCtD
Chlorpromazine—Loss of consciousness—Sorafenib—thyroid cancer	0.00088	0.00583	CcSEcCtD
Chlorpromazine—CHRM3—thyroid gland—thyroid cancer	0.000877	0.0139	CbGeAlD
Chlorpromazine—Cough—Sorafenib—thyroid cancer	0.000874	0.00579	CcSEcCtD
Chlorpromazine—CHRM1—head—thyroid cancer	0.000869	0.0138	CbGeAlD
Chlorpromazine—Gait disturbance—Epirubicin—thyroid cancer	0.000867	0.00575	CcSEcCtD
Chlorpromazine—HTR2B—head—thyroid cancer	0.000864	0.0137	CbGeAlD
Chlorpromazine—CALM2—thyroid gland—thyroid cancer	0.000858	0.0136	CbGeAlD
Chlorpromazine—CALM1—thyroid gland—thyroid cancer	0.000854	0.0136	CbGeAlD
Chlorpromazine—Dermatitis contact—Epirubicin—thyroid cancer	0.000836	0.00554	CcSEcCtD
Chlorpromazine—Dry mouth—Sorafenib—thyroid cancer	0.000834	0.00553	CcSEcCtD
Chlorpromazine—Dyskinesia—Doxorubicin—thyroid cancer	0.000833	0.00552	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000817	0.00542	CcSEcCtD
Chlorpromazine—Infection—Sorafenib—thyroid cancer	0.000812	0.00538	CcSEcCtD
Chlorpromazine—Shock—Sorafenib—thyroid cancer	0.000804	0.00533	CcSEcCtD
Chlorpromazine—Gait disturbance—Doxorubicin—thyroid cancer	0.000802	0.00532	CcSEcCtD
Chlorpromazine—Dizziness—Vandetanib—thyroid cancer	0.000801	0.00531	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Epirubicin—thyroid cancer	0.000795	0.00527	CcSEcCtD
Chlorpromazine—HRH1—trachea—thyroid cancer	0.000788	0.0125	CbGeAlD
Chlorpromazine—CHRM3—head—thyroid cancer	0.000778	0.0123	CbGeAlD
Chlorpromazine—HTR1A—head—thyroid cancer	0.000775	0.0123	CbGeAlD
Chlorpromazine—Dermatitis contact—Doxorubicin—thyroid cancer	0.000774	0.00513	CcSEcCtD
Chlorpromazine—ADRA2A—trachea—thyroid cancer	0.000774	0.0123	CbGeAlD
Chlorpromazine—CALM2—head—thyroid cancer	0.000761	0.0121	CbGeAlD
Chlorpromazine—CALM1—head—thyroid cancer	0.000758	0.012	CbGeAlD
Chlorpromazine—HTR7—head—thyroid cancer	0.00074	0.0117	CbGeAlD
Chlorpromazine—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000735	0.00487	CcSEcCtD
Chlorpromazine—Dyspnoea—Sorafenib—thyroid cancer	0.000728	0.00483	CcSEcCtD
Chlorpromazine—BCHE—thyroid gland—thyroid cancer	0.000715	0.0114	CbGeAlD
Chlorpromazine—ADRA1A—head—thyroid cancer	0.000714	0.0113	CbGeAlD
Chlorpromazine—DRD2—head—thyroid cancer	0.0007	0.0111	CbGeAlD
Chlorpromazine—Photosensitivity—Epirubicin—thyroid cancer	0.0007	0.00464	CcSEcCtD
Chlorpromazine—Constipation—Sorafenib—thyroid cancer	0.000699	0.00463	CcSEcCtD
Chlorpromazine—KCNH2—head—thyroid cancer	0.00069	0.0109	CbGeAlD
Chlorpromazine—CALM3—lymph node—thyroid cancer	0.000679	0.0108	CbGeAlD
Chlorpromazine—CYP1A2—thyroid gland—thyroid cancer	0.000666	0.0106	CbGeAlD
Chlorpromazine—HTR2A—trachea—thyroid cancer	0.000658	0.0104	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000651	0.00432	CcSEcCtD
Chlorpromazine—Photosensitivity—Doxorubicin—thyroid cancer	0.000647	0.00429	CcSEcCtD
Chlorpromazine—Body temperature increased—Sorafenib—thyroid cancer	0.000646	0.00428	CcSEcCtD
Chlorpromazine—BCHE—head—thyroid cancer	0.000635	0.0101	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000635	0.00421	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Epirubicin—thyroid cancer	0.00063	0.00417	CcSEcCtD
Chlorpromazine—ALB—lymph node—thyroid cancer	0.000629	0.00997	CbGeAlD
Chlorpromazine—ADRA2A—thyroid gland—thyroid cancer	0.000612	0.00971	CbGeAlD
Chlorpromazine—HTR2B—lymph node—thyroid cancer	0.000605	0.0096	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000602	0.00399	CcSEcCtD
Chlorpromazine—Hypersensitivity—Sorafenib—thyroid cancer	0.000602	0.00399	CcSEcCtD
Chlorpromazine—CYP2E1—thyroid gland—thyroid cancer	0.000599	0.0095	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000587	0.00389	CcSEcCtD
Chlorpromazine—Cardiac arrest—Epirubicin—thyroid cancer	0.000584	0.00387	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000582	0.00386	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000561	0.00372	CcSEcCtD
Chlorpromazine—HRH1—head—thyroid cancer	0.000553	0.00877	CbGeAlD
Chlorpromazine—ADRA2A—head—thyroid cancer	0.000543	0.00861	CbGeAlD
Chlorpromazine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000541	0.00358	CcSEcCtD
Chlorpromazine—Dizziness—Sorafenib—thyroid cancer	0.00054	0.00358	CcSEcCtD
Chlorpromazine—CALM2—lymph node—thyroid cancer	0.000533	0.00846	CbGeAlD
Chlorpromazine—CYP2E1—head—thyroid cancer	0.000531	0.00843	CbGeAlD
Chlorpromazine—Dysphagia—Epirubicin—thyroid cancer	0.000531	0.00352	CcSEcCtD
Chlorpromazine—Influenza—Epirubicin—thyroid cancer	0.000531	0.00352	CcSEcCtD
Chlorpromazine—Asthma—Epirubicin—thyroid cancer	0.000531	0.00352	CcSEcCtD
Chlorpromazine—CALM1—lymph node—thyroid cancer	0.000531	0.00842	CbGeAlD
Chlorpromazine—Eosinophilia—Epirubicin—thyroid cancer	0.000526	0.00349	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000519	0.00344	CcSEcCtD
Chlorpromazine—Pancytopenia—Epirubicin—thyroid cancer	0.000504	0.00334	CcSEcCtD
Chlorpromazine—Influenza—Doxorubicin—thyroid cancer	0.000491	0.00326	CcSEcCtD
Chlorpromazine—Asthma—Doxorubicin—thyroid cancer	0.000491	0.00326	CcSEcCtD
Chlorpromazine—Dysphagia—Doxorubicin—thyroid cancer	0.000491	0.00326	CcSEcCtD
Chlorpromazine—Eosinophilia—Doxorubicin—thyroid cancer	0.000486	0.00322	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000485	0.00321	CcSEcCtD
Chlorpromazine—KCNH2—lymph node—thyroid cancer	0.000483	0.00766	CbGeAlD
Chlorpromazine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000479	0.00318	CcSEcCtD
Chlorpromazine—Drowsiness—Epirubicin—thyroid cancer	0.000473	0.00314	CcSEcCtD
Chlorpromazine—Pancytopenia—Doxorubicin—thyroid cancer	0.000467	0.00309	CcSEcCtD
Chlorpromazine—HTR2A—head—thyroid cancer	0.000462	0.00732	CbGeAlD
Chlorpromazine—Jaundice—Epirubicin—thyroid cancer	0.000461	0.00306	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000448	0.00297	CcSEcCtD
Chlorpromazine—BCHE—lymph node—thyroid cancer	0.000444	0.00705	CbGeAlD
Chlorpromazine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000443	0.00294	CcSEcCtD
Chlorpromazine—Agranulocytosis—Epirubicin—thyroid cancer	0.000442	0.00293	CcSEcCtD
Chlorpromazine—Drowsiness—Doxorubicin—thyroid cancer	0.000438	0.0029	CcSEcCtD
Chlorpromazine—ABCB1—trachea—thyroid cancer	0.000431	0.00684	CbGeAlD
Chlorpromazine—Jaundice—Doxorubicin—thyroid cancer	0.000427	0.00283	CcSEcCtD
Chlorpromazine—CYP2D6—head—thyroid cancer	0.000421	0.00667	CbGeAlD
Chlorpromazine—Oedema peripheral—Epirubicin—thyroid cancer	0.000419	0.00278	CcSEcCtD
Chlorpromazine—Visual impairment—Epirubicin—thyroid cancer	0.00041	0.00272	CcSEcCtD
Chlorpromazine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000409	0.00271	CcSEcCtD
Chlorpromazine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000387	0.00257	CcSEcCtD
Chlorpromazine—HRH1—lymph node—thyroid cancer	0.000387	0.00614	CbGeAlD
Chlorpromazine—ADRA2A—lymph node—thyroid cancer	0.00038	0.00603	CbGeAlD
Chlorpromazine—Visual impairment—Doxorubicin—thyroid cancer	0.000379	0.00251	CcSEcCtD
Chlorpromazine—Nervousness—Epirubicin—thyroid cancer	0.000359	0.00238	CcSEcCtD
Chlorpromazine—Muscle spasms—Epirubicin—thyroid cancer	0.000356	0.00236	CcSEcCtD
Chlorpromazine—ABCB1—thyroid gland—thyroid cancer	0.000341	0.00541	CbGeAlD
Chlorpromazine—Nervousness—Doxorubicin—thyroid cancer	0.000332	0.0022	CcSEcCtD
Chlorpromazine—Syncope—Epirubicin—thyroid cancer	0.000332	0.0022	CcSEcCtD
Chlorpromazine—Leukopenia—Epirubicin—thyroid cancer	0.000331	0.0022	CcSEcCtD
Chlorpromazine—Muscle spasms—Doxorubicin—thyroid cancer	0.000329	0.00218	CcSEcCtD
Chlorpromazine—Loss of consciousness—Epirubicin—thyroid cancer	0.000325	0.00216	CcSEcCtD
Chlorpromazine—Cough—Epirubicin—thyroid cancer	0.000323	0.00214	CcSEcCtD
Chlorpromazine—Convulsion—Epirubicin—thyroid cancer	0.000321	0.00212	CcSEcCtD
Chlorpromazine—Dry mouth—Epirubicin—thyroid cancer	0.000308	0.00204	CcSEcCtD
Chlorpromazine—Syncope—Doxorubicin—thyroid cancer	0.000307	0.00204	CcSEcCtD
Chlorpromazine—Leukopenia—Doxorubicin—thyroid cancer	0.000306	0.00203	CcSEcCtD
Chlorpromazine—ABCB1—head—thyroid cancer	0.000303	0.0048	CbGeAlD
Chlorpromazine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000302	0.002	CcSEcCtD
Chlorpromazine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000301	0.00199	CcSEcCtD
Chlorpromazine—Infection—Epirubicin—thyroid cancer	0.0003	0.00199	CcSEcCtD
Chlorpromazine—Cough—Doxorubicin—thyroid cancer	0.000299	0.00198	CcSEcCtD
Chlorpromazine—Shock—Epirubicin—thyroid cancer	0.000297	0.00197	CcSEcCtD
Chlorpromazine—Convulsion—Doxorubicin—thyroid cancer	0.000297	0.00197	CcSEcCtD
Chlorpromazine—Tachycardia—Epirubicin—thyroid cancer	0.000295	0.00195	CcSEcCtD
Chlorpromazine—Dry mouth—Doxorubicin—thyroid cancer	0.000285	0.00189	CcSEcCtD
Chlorpromazine—Hypotension—Epirubicin—thyroid cancer	0.000282	0.00187	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000279	0.00185	CcSEcCtD
Chlorpromazine—Infection—Doxorubicin—thyroid cancer	0.000278	0.00184	CcSEcCtD
Chlorpromazine—Shock—Doxorubicin—thyroid cancer	0.000275	0.00182	CcSEcCtD
Chlorpromazine—Insomnia—Epirubicin—thyroid cancer	0.000273	0.00181	CcSEcCtD
Chlorpromazine—Tachycardia—Doxorubicin—thyroid cancer	0.000273	0.00181	CcSEcCtD
Chlorpromazine—Dyspnoea—Epirubicin—thyroid cancer	0.000269	0.00178	CcSEcCtD
Chlorpromazine—Somnolence—Epirubicin—thyroid cancer	0.000268	0.00178	CcSEcCtD
Chlorpromazine—Hypotension—Doxorubicin—thyroid cancer	0.000261	0.00173	CcSEcCtD
Chlorpromazine—Constipation—Epirubicin—thyroid cancer	0.000258	0.00171	CcSEcCtD
Chlorpromazine—Insomnia—Doxorubicin—thyroid cancer	0.000253	0.00168	CcSEcCtD
Chlorpromazine—Dyspnoea—Doxorubicin—thyroid cancer	0.000249	0.00165	CcSEcCtD
Chlorpromazine—Somnolence—Doxorubicin—thyroid cancer	0.000248	0.00165	CcSEcCtD
Chlorpromazine—Constipation—Doxorubicin—thyroid cancer	0.000239	0.00158	CcSEcCtD
Chlorpromazine—Body temperature increased—Epirubicin—thyroid cancer	0.000239	0.00158	CcSEcCtD
Chlorpromazine—Hypersensitivity—Epirubicin—thyroid cancer	0.000222	0.00147	CcSEcCtD
Chlorpromazine—Body temperature increased—Doxorubicin—thyroid cancer	0.000221	0.00146	CcSEcCtD
Chlorpromazine—ABCB1—lymph node—thyroid cancer	0.000212	0.00336	CbGeAlD
Chlorpromazine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000206	0.00136	CcSEcCtD
Chlorpromazine—Dizziness—Epirubicin—thyroid cancer	0.0002	0.00132	CcSEcCtD
Chlorpromazine—Dizziness—Doxorubicin—thyroid cancer	0.000185	0.00122	CcSEcCtD
Chlorpromazine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.05e-05	4.75e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—AKT1—thyroid cancer	1.05e-05	4.74e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—NRAS—thyroid cancer	1.04e-05	4.68e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PPARG—thyroid cancer	1.03e-05	4.67e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.03e-05	4.65e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.03e-05	4.64e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—PTEN—thyroid cancer	1.03e-05	4.63e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—PTEN—thyroid cancer	1.03e-05	4.63e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.02e-05	4.62e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—AKT1—thyroid cancer	1.02e-05	4.59e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—AKT1—thyroid cancer	1.02e-05	4.59e-05	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—AKT1—thyroid cancer	1.01e-05	4.55e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—AKT1—thyroid cancer	1.01e-05	4.55e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	1.01e-05	4.54e-05	CbGpPWpGaD
Chlorpromazine—ABCB11—Metabolism—AKT1—thyroid cancer	1e-05	4.53e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—NRAS—thyroid cancer	1e-05	4.52e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—NRAS—thyroid cancer	1e-05	4.52e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—NRAS—thyroid cancer	9.92e-06	4.48e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—KRAS—thyroid cancer	9.92e-06	4.48e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—KRAS—thyroid cancer	9.91e-06	4.48e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	9.91e-06	4.47e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	9.86e-06	4.45e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PTEN—thyroid cancer	9.8e-06	4.42e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—PTEN—thyroid cancer	9.79e-06	4.42e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—NRAS—thyroid cancer	9.79e-06	4.42e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	9.79e-06	4.42e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	9.77e-06	4.41e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—AKT1—thyroid cancer	9.75e-06	4.4e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—AKT1—thyroid cancer	9.75e-06	4.4e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—BRAF—thyroid cancer	9.74e-06	4.4e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—AKT1—thyroid cancer	9.65e-06	4.36e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	9.56e-06	4.32e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	9.52e-06	4.3e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—KRAS—thyroid cancer	9.49e-06	4.28e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—PTEN—thyroid cancer	9.47e-06	4.28e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—PTEN—thyroid cancer	9.47e-06	4.28e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PTGS2—thyroid cancer	9.47e-06	4.27e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—NRAS—thyroid cancer	9.46e-06	4.27e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	9.44e-06	4.26e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—BRAF—thyroid cancer	9.42e-06	4.25e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—BRAF—thyroid cancer	9.42e-06	4.25e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PTGS2—thyroid cancer	9.41e-06	4.25e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	9.33e-06	4.21e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	9.28e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	9.28e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—NRAS—thyroid cancer	9.16e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—NRAS—thyroid cancer	9.16e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	9.13e-06	4.12e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	9.11e-06	4.11e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	9.11e-06	4.11e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PTGS2—thyroid cancer	9.1e-06	4.11e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PTGS2—thyroid cancer	9.1e-06	4.11e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	9.08e-06	4.1e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PPARG—thyroid cancer	9.06e-06	4.09e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—KRAS—thyroid cancer	9.06e-06	4.09e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	9.05e-06	4.09e-05	CbGpPWpGaD
Chlorpromazine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	9.02e-06	4.07e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PTEN—thyroid cancer	8.99e-06	4.06e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	8.96e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	8.94e-06	4.04e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—KRAS—thyroid cancer	8.92e-06	4.03e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	8.89e-06	4.01e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	8.88e-06	4.01e-05	CbGpPWpGaD
Chlorpromazine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	8.86e-06	4e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—RXRA—thyroid cancer	8.84e-06	3.99e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	8.83e-06	3.99e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—TP53—thyroid cancer	8.82e-06	3.98e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—TP53—thyroid cancer	8.81e-06	3.98e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	8.8e-06	3.97e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—NRAS—thyroid cancer	8.74e-06	3.95e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	8.72e-06	3.94e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CCND1—thyroid cancer	8.7e-06	3.93e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	8.69e-06	3.92e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—KRAS—thyroid cancer	8.62e-06	3.89e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—KRAS—thyroid cancer	8.62e-06	3.89e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	8.56e-06	3.87e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CCND1—thyroid cancer	8.54e-06	3.86e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—KRAS—thyroid cancer	8.54e-06	3.86e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PPARG—thyroid cancer	8.54e-06	3.86e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	8.53e-06	3.85e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CCND1—thyroid cancer	8.51e-06	3.84e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	8.49e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CCND1—thyroid cancer	8.49e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—NRAS—thyroid cancer	8.45e-06	3.82e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—NRAS—thyroid cancer	8.45e-06	3.82e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—HRAS—thyroid cancer	8.43e-06	3.81e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—TP53—thyroid cancer	8.43e-06	3.81e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—KRAS—thyroid cancer	8.43e-06	3.81e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—HRAS—thyroid cancer	8.42e-06	3.8e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CCND1—thyroid cancer	8.41e-06	3.8e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PTEN—thyroid cancer	8.4e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	8.38e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	8.31e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	8.26e-06	3.73e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PTEN—thyroid cancer	8.26e-06	3.73e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PTEN—thyroid cancer	8.24e-06	3.72e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PTEN—thyroid cancer	8.22e-06	3.71e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PTEN—thyroid cancer	8.2e-06	3.7e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	8.19e-06	3.7e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PTEN—thyroid cancer	8.19e-06	3.7e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—KRAS—thyroid cancer	8.15e-06	3.68e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTGS2—thyroid cancer	8.14e-06	3.67e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	8.13e-06	3.67e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PTEN—thyroid cancer	8.11e-06	3.66e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	8.09e-06	3.65e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	8.08e-06	3.65e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—HRAS—thyroid cancer	8.06e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	8.06e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TP53—thyroid cancer	8.05e-06	3.63e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	8.04e-06	3.63e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	8.02e-06	3.62e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	7.99e-06	3.61e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PTEN—thyroid cancer	7.93e-06	3.58e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PTEN—thyroid cancer	7.93e-06	3.58e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	7.91e-06	3.57e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	7.89e-06	3.56e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—KRAS—thyroid cancer	7.88e-06	3.56e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—KRAS—thyroid cancer	7.88e-06	3.56e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	7.79e-06	3.52e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—HRAS—thyroid cancer	7.7e-06	3.48e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—thyroid cancer	7.59e-06	3.43e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—HRAS—thyroid cancer	7.58e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—KRAS—thyroid cancer	7.52e-06	3.4e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	7.52e-06	3.39e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—NRAS—thyroid cancer	7.49e-06	3.38e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—thyroid cancer	7.49e-06	3.38e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—AKT1—thyroid cancer	7.45e-06	3.36e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—AKT1—thyroid cancer	7.44e-06	3.36e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	7.37e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—NRAS—thyroid cancer	7.36e-06	3.32e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	7.34e-06	3.32e-05	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—AKT1—thyroid cancer	7.34e-06	3.32e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	7.33e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NRAS—thyroid cancer	7.33e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—HRAS—thyroid cancer	7.33e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—HRAS—thyroid cancer	7.33e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NRAS—thyroid cancer	7.31e-06	3.3e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	7.31e-06	3.3e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—KRAS—thyroid cancer	7.28e-06	3.29e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—KRAS—thyroid cancer	7.28e-06	3.29e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—HRAS—thyroid cancer	7.26e-06	3.28e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NRAS—thyroid cancer	7.24e-06	3.27e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PPARG—thyroid cancer	7.23e-06	3.27e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	7.22e-06	3.26e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—HRAS—thyroid cancer	7.16e-06	3.23e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTGS2—thyroid cancer	7.13e-06	3.22e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—AKT1—thyroid cancer	7.12e-06	3.22e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCND1—thyroid cancer	7.11e-06	3.21e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTEN—thyroid cancer	7.09e-06	3.2e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	6.99e-06	3.16e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HRAS—thyroid cancer	6.92e-06	3.13e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCND1—thyroid cancer	6.87e-06	3.1e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCND1—thyroid cancer	6.87e-06	3.1e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PTEN—thyroid cancer	6.86e-06	3.1e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—AKT1—thyroid cancer	6.8e-06	3.07e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTGS2—thyroid cancer	6.72e-06	3.03e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	6.71e-06	3.03e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HRAS—thyroid cancer	6.7e-06	3.02e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HRAS—thyroid cancer	6.7e-06	3.02e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—AKT1—thyroid cancer	6.69e-06	3.02e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PTEN—thyroid cancer	6.63e-06	3e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PTEN—thyroid cancer	6.63e-06	3e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—thyroid cancer	6.53e-06	2.95e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—thyroid cancer	6.49e-06	2.93e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—AKT1—thyroid cancer	6.47e-06	2.92e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—AKT1—thyroid cancer	6.47e-06	2.92e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—KRAS—thyroid cancer	6.45e-06	2.91e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—AKT1—thyroid cancer	6.41e-06	2.89e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—HRAS—thyroid cancer	6.39e-06	2.89e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	6.34e-06	2.86e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—KRAS—thyroid cancer	6.33e-06	2.86e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—AKT1—thyroid cancer	6.32e-06	2.86e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—KRAS—thyroid cancer	6.31e-06	2.85e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—KRAS—thyroid cancer	6.29e-06	2.84e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	6.24e-06	2.82e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—KRAS—thyroid cancer	6.23e-06	2.81e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTEN—thyroid cancer	6.22e-06	2.81e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	6.22e-06	2.81e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	6.21e-06	2.81e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	6.21e-06	2.8e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—HRAS—thyroid cancer	6.18e-06	2.79e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—HRAS—thyroid cancer	6.18e-06	2.79e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NRAS—thyroid cancer	6.12e-06	2.76e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—AKT1—thyroid cancer	6.11e-06	2.76e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—AKT1—thyroid cancer	6.11e-06	2.76e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	5.94e-06	2.68e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NRAS—thyroid cancer	5.92e-06	2.67e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NRAS—thyroid cancer	5.92e-06	2.67e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—AKT1—thyroid cancer	5.91e-06	2.67e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—AKT1—thyroid cancer	5.91e-06	2.67e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTEN—thyroid cancer	5.86e-06	2.65e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	5.77e-06	2.61e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—thyroid cancer	5.73e-06	2.59e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.69e-06	2.57e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—AKT1—thyroid cancer	5.65e-06	2.55e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—AKT1—thyroid cancer	5.64e-06	2.55e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—thyroid cancer	5.64e-06	2.55e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—thyroid cancer	5.63e-06	2.54e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—thyroid cancer	5.61e-06	2.53e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—thyroid cancer	5.59e-06	2.52e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARG—thyroid cancer	5.58e-06	2.52e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—thyroid cancer	5.54e-06	2.5e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	5.52e-06	2.49e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	5.51e-06	2.49e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	5.48e-06	2.48e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—HRAS—thyroid cancer	5.48e-06	2.47e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—AKT1—thyroid cancer	5.46e-06	2.47e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—AKT1—thyroid cancer	5.46e-06	2.47e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	5.39e-06	2.44e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—HRAS—thyroid cancer	5.38e-06	2.43e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—HRAS—thyroid cancer	5.36e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—HRAS—thyroid cancer	5.35e-06	2.41e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—HRAS—thyroid cancer	5.3e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	5.28e-06	2.38e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—KRAS—thyroid cancer	5.27e-06	2.38e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	5.25e-06	2.37e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—AKT1—thyroid cancer	5.18e-06	2.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	5.13e-06	2.32e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—KRAS—thyroid cancer	5.09e-06	2.3e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—KRAS—thyroid cancer	5.09e-06	2.3e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTEN—thyroid cancer	4.96e-06	2.24e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	4.91e-06	2.22e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—AKT1—thyroid cancer	4.84e-06	2.19e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	4.76e-06	2.15e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—AKT1—thyroid cancer	4.76e-06	2.15e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—AKT1—thyroid cancer	4.75e-06	2.15e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—AKT1—thyroid cancer	4.74e-06	2.14e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—AKT1—thyroid cancer	4.73e-06	2.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—AKT1—thyroid cancer	4.72e-06	2.13e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—thyroid cancer	4.68e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—AKT1—thyroid cancer	4.68e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	4.66e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—AKT1—thyroid cancer	4.57e-06	2.06e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—AKT1—thyroid cancer	4.57e-06	2.06e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—thyroid cancer	4.53e-06	2.04e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—thyroid cancer	4.53e-06	2.04e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—HRAS—thyroid cancer	4.48e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.39e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	4.33e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—HRAS—thyroid cancer	4.33e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—HRAS—thyroid cancer	4.33e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—AKT1—thyroid cancer	4.09e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—AKT1—thyroid cancer	3.95e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTEN—thyroid cancer	3.83e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—AKT1—thyroid cancer	3.82e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—AKT1—thyroid cancer	3.82e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—AKT1—thyroid cancer	3.58e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—AKT1—thyroid cancer	3.38e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—AKT1—thyroid cancer	2.86e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.21e-06	9.97e-06	CbGpPWpGaD
